This is the author accepted manuscript. The final version is available from the American Diabetes Association via the DOI in this record Data Availability: Further information about the data is available from the corresponding author upon request.C-peptide declines in type 1 diabetes although many long-duration patients retain low, but detectable levels. Histological analyses confirm that beta cells can remain following type 1 diabetes onset. We explored the trends observed in C-peptide decline in UK Genetic Resource Investigating Diabetes (UK GRID) cohort (N=4,079), with beta cell loss in pancreas donors from the network for Pancreatic Organ donors with Diabetes (nPOD) biobank and the Exeter Archival Diabetes Biobank (EADB) (combined N=2...
This is the author version of an article submitted to Diabetes Care. The definitive version is avail...
OBJECTIVE: Body weight-related insulin resistance probably plays a role in progression to type 1 dia...
Objective: The decline in C-peptide in the 5 years after diagnosis of type 1 diabetes has been well ...
This is the author accepted manuscript. The final version is available from the American Diabetes As...
Objective: C-peptide is conventionally used in assessing pancreatic function in patients with diabet...
PublishedThis is the final version of the article. Available from Springer Verlag via the DOI in thi...
This study was done to characterize the natural course of C-peptide levels in patients with type 1 d...
Introduction: The progression to insulin deficiency in type 1 diabetes is heterogenous. This study a...
Interpretation of clinical trials to alter the decline in β-cell function after diagnosis of type 1 ...
Up until recently, the prevailing dogma was that insulin secretion ceased within a couple of years a...
C-peptide secretion is currently the only available clinical biomarker to measure residual β-cell fu...
The objective of this cross-sectional study was to explore the relationship of detectable C-peptide ...
Aims/hypothesis: We studied the decline of C-peptide during the first year after diagnosis of Type 1...
Background The inability to produce insulin endogenously precipitates the clinical symptoms of type...
Objective: Body weight related insulin resistance probably plays a role in progression to type 1 dia...
This is the author version of an article submitted to Diabetes Care. The definitive version is avail...
OBJECTIVE: Body weight-related insulin resistance probably plays a role in progression to type 1 dia...
Objective: The decline in C-peptide in the 5 years after diagnosis of type 1 diabetes has been well ...
This is the author accepted manuscript. The final version is available from the American Diabetes As...
Objective: C-peptide is conventionally used in assessing pancreatic function in patients with diabet...
PublishedThis is the final version of the article. Available from Springer Verlag via the DOI in thi...
This study was done to characterize the natural course of C-peptide levels in patients with type 1 d...
Introduction: The progression to insulin deficiency in type 1 diabetes is heterogenous. This study a...
Interpretation of clinical trials to alter the decline in β-cell function after diagnosis of type 1 ...
Up until recently, the prevailing dogma was that insulin secretion ceased within a couple of years a...
C-peptide secretion is currently the only available clinical biomarker to measure residual β-cell fu...
The objective of this cross-sectional study was to explore the relationship of detectable C-peptide ...
Aims/hypothesis: We studied the decline of C-peptide during the first year after diagnosis of Type 1...
Background The inability to produce insulin endogenously precipitates the clinical symptoms of type...
Objective: Body weight related insulin resistance probably plays a role in progression to type 1 dia...
This is the author version of an article submitted to Diabetes Care. The definitive version is avail...
OBJECTIVE: Body weight-related insulin resistance probably plays a role in progression to type 1 dia...
Objective: The decline in C-peptide in the 5 years after diagnosis of type 1 diabetes has been well ...